Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on Reducing Asthma Medication with Tezepelumab in Patients Aged 12 to 80 with Severe Asthma

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    Belgium Bulgaria Denmark France Germany Italy +1
  • Study on Acute Lymphoblastic Leukemia Treatment in Children and Adolescents Using Bortezomib, Blinatumomab, and Methotrexate Combination

    Not recruiting

    3 1 1 1
    Poland
  • Study on EHSG-KF for Treating Partial Deep Dermal and Full Thickness Burns in Adults and Adolescents

    Not recruiting

    2 1 1
    Investigated Diseases:
    The Netherlands
  • Study of Metronomic Oral Vinorelbine with Durvalumab and Tremelimumab for Patients with Advanced Solid Tumors

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Study on the Safety and Effectiveness of Hydroxypropylbetadex and Miglustat for Patients with Niemann-Pick Disease Type C1

    Not recruiting

    3 1 1
    Investigated Diseases:
    Germany Italy Poland Spain
  • Study on Monkeypox Virus Disease: Effects of Tecovirimat in Patients with and without Antiviral Treatment

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France Ireland Italy The Netherlands Norway +2
  • Live Attenuated Influenza Vaccine (LAIV) and Immune Response in the Nasopharynx of Young Children with Influenza

    Not recruiting

    3 1 1 1
    The Netherlands
  • Study on the Long-Term Safety and Effectiveness of Vosoritide for Children with Achondroplasia

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany Spain
  • Long-term study of dabrafenib and trametinib in children and adolescents with cancers that have V600 mutation

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Belgium Czechia Denmark Finland France Germany +4
  • Study of BMN 351 given by intravenous infusion to evaluate safety and tolerability in patients with Duchenne Muscular Dystrophy

    Not recruiting

    2 1 1
    Investigated Diseases:
    Italy The Netherlands Spain